Omics! Omics!

Last week the UK’s CMA published a proposal submitted by Illumina and PacBio to save their merger. This was then published in a revised, see...

Today Genapsys launches their sequencer into the U.S. market, with worldwide launch next year.  They also received a new round ($90M) of fin...

Today the United Kingdom's Competition and Merger Authority (CMA) issued their preliminary report on the proposed acquisition of Pacifi...

Two weeks ago QIAGEN announced they will discontinue development of their GeneReader short read instrument and move their portfolio of gene ...

Interesting news today on the PacBio front: as reported by GenomeWeb , Illumina announced that their walkaway date for the acquisition has b...

I've written far more than I expected to on the PacBio merger, with it dominating my output here this summer save that recent dip in the...

I spent a day recently taking Amazon's "AWS Technical Essentials" course.  I had originally opted not to go, but a summons wen...

A core purpose of this space is to explore the current state of genomics technology.  Much of the time this is via distilling news reports, ...

The proposed PacBio-ILMN Merger remains an interesting spectator sport, with the UK's CMA looking for public input for the next round.  ...

As part two of a yet-to-be-determined number of pieces on the UK's CMA preliminary analysis of the proposed Pacific Biosciences acquisit...

After writing my two recent pieces on the business side of the long read industry I planned, after a recent extended family vacation, to try...

When Illumina announced its proposed acquisition of Pacific Biosciences last fall, an immediate question arose as to whether the deal would ...

There's an unfortunate chain of events that may end up causing a headache for Oxford Nanopore, and it's completely outside their con...

I noted in my roundup of Oxford Nanopore technical announcements that I loved the Plongle concept.  This is really both a new application-sp...

In the coverage of ONT's announcements at London Calling , I specifically left out one of Clive's Skunk Works projects.  This would ...

The annual big Clive Brown London Calling talk had a twist this year  Brown introduced a set of senior lieutenants at Oxford Nanopore and th...

The first half day of London Calling has already delivered the usual mix of scientific excitement.  The prospect of lives, particularly thos...

London Calling is this week, so get ready for lots of Oxford Nanopore in my Twitter channel and if I'm on the ball, in this space.  ONT ...

There's a paper this week in Nature announcing an E.coli genome which has had two serine codons ( UCA , UCG ) and one stop codon ( UAG...

When I announced recently that I had moved over to Ginkgo Bioworks, I was compelled to leave out an important part of that story.  Indeed, ...